High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy
Efficacy of High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy: A Double-blinded, Randomized Controlled Trail
1 other identifier
interventional
24
1 country
1
Brief Summary
The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2022
CompletedFirst Posted
Study publicly available on registry
August 2, 2022
CompletedStudy Start
First participant enrolled
January 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedResults Posted
Study results publicly available
February 25, 2025
CompletedFebruary 25, 2025
February 1, 2025
1.2 years
July 29, 2022
November 19, 2024
February 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Visual Analogue Scale(VAS)
The Visual Analog Scale (VAS) was used to measure pain intensity. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain. Higher scores indicate worse outcomes.
baseline, immediate after treatment, 4 weeks, 12 weeks
Secondary Outcomes (4)
Change in Total Score of Shoulder Pain and Disability Index (SPADI)
baseline, immediate after treatment, 4 weeks, 12 weeks
Changes of Shoulder Range of Motion in Active Flexion
baseline, immediate after treatment, 4 weeks, 12 weeks
Changes of Shoulder Range of Motion in Active Abduction
baseline, immediately after treatment, 4 weeks, 12 weeks
Changes of Shoulder Range of Motion in Active Internal Rotation
baseline, immediately after treatment, 4 weeks, 12 weeks
Study Arms (2)
physiotherapy and high-PEMF
EXPERIMENTALThe patient receives physiotherapy under the physiotherapist's guidance and high-PEMF therapy for three weeks, following two sessions a week.
physiotherapy and sham high-PEMF
SHAM COMPARATORThe patient receives physiotherapy under the physiotherapist's guidance and sham high-PEMF therapy for three weeks, following two sessions a week.
Interventions
The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A normal energy of high-PEMF with a rate of 2 pulse per second is applied to the patient.
The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(normal energy, a rate of 2 pulse per second) with the difference that the energy output doesn't export to the patient.
Physiotherapy includes shoulder range of motion (ROM), stretching and muscle strengthening exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.
Eligibility Criteria
You may qualify if:
- age between 20 to 75 years old
- persistent shoulder pain for at least 3 months and pain VAS score \>=5
- positive result in any of the following physical examinations: Hawkins-Kennedy, Neer or Jobe tests
- confirmed rotator cuff tendinopathy by ultrasonography or MRI
You may not qualify if:
- complete or full-thickness tear of rotator cuff found by ultrasonography or MRI
- previous shoulder surgery
- previous history of severe trauma in shoulder
- cervical radiculopathy related shoulder pain or referred pain
- other shoulder diseases: adhesive capsulitis, calcifying tendinopathy, radiology-confirmed acromion type III, shoulder instability, degenerative osteoarthritis, labral tear
- present with any of the following systemic diseases: active infection, sever and uncontrolled medical condition, cancer, immune-related or rheumatoid arthritis, hyperuricemia and gout
- previous treatment with articular or subacromial steroid injections within the last 3 months
- cognitive impairment with loss of ability to sign the agreement and receive rehabilitation
- pregnancy or lactating women
- has any of the following contraindications: Carriers of pacemakers, internal defibrillators,internal metal implants (locally dependent), Cochlea implants, metallic stents, insulin pumps
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tri-service general hospital
Taipei, Neihu, 11490, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Lai Chia-Ying
- Organization
- Tri-service general hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Liang cheng Chen, MD, MS
Department of Physical Medicine and Rehabilitation, Tri-Service General
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 29, 2022
First Posted
August 2, 2022
Study Start
January 31, 2023
Primary Completion
April 8, 2024
Study Completion
August 30, 2024
Last Updated
February 25, 2025
Results First Posted
February 25, 2025
Record last verified: 2025-02